Marksans Pharma Ltd
NSE:MARKSANS
Marksans Pharma Ltd
NSE:MARKSANS
Price:
180.95
INR
-0.32%
Market Closed
Market Cap:
₹82B
Balance Sheet
Balance Sheet Decomposition
Marksans Pharma Ltd
Marksans Pharma Ltd
Balance Sheet Decomposition is not available for
Marksans Pharma Ltd
Marksans Pharma Ltd
Balance Sheet
Marksans Pharma Ltd
Marksans Pharma Ltd
Currency: INR
| Mar-2003 | Mar-2004 | Mar-2005 | Mar-2006 | Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
15
|
43
|
97
|
1 976
|
1 587
|
614
|
99
|
121
|
62
|
53
|
155
|
138
|
1 495
|
350
|
250
|
397
|
329
|
931
|
516
|
2 064
|
3 824
|
4 958
|
|
| Cash |
15
|
43
|
97
|
1 976
|
1 587
|
614
|
99
|
121
|
62
|
53
|
155
|
138
|
1 495
|
350
|
250
|
397
|
329
|
931
|
516
|
1 567
|
875
|
2 786
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
497
|
2 949
|
2 172
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
2
|
125
|
234
|
244
|
167
|
0
|
329
|
356
|
0
|
0
|
0
|
0
|
0
|
1 578
|
1 403
|
3 326
|
2 088
|
|
| Total Receivables |
103
|
576
|
690
|
636
|
746
|
875
|
1 188
|
1 151
|
1 113
|
1 199
|
1 504
|
1 934
|
1 935
|
2 371
|
2 685
|
1 826
|
1 836
|
2 434
|
2 714
|
3 978
|
4 195
|
6 093
|
|
| Accounts Receivables |
84
|
535
|
616
|
507
|
542
|
60
|
61
|
71
|
989
|
1 128
|
1 313
|
1 696
|
1 835
|
2 173
|
2 476
|
1 769
|
1 766
|
2 434
|
2 714
|
3 948
|
4 168
|
5 422
|
|
| Other Receivables |
19
|
41
|
74
|
129
|
204
|
815
|
1 127
|
1 080
|
124
|
71
|
191
|
238
|
100
|
198
|
209
|
57
|
70
|
0
|
0
|
30
|
26
|
671
|
|
| Inventory |
143
|
367
|
524
|
789
|
1 239
|
1 394
|
1 191
|
1 045
|
672
|
734
|
777
|
1 026
|
1 301
|
1 678
|
1 901
|
2 181
|
2 932
|
2 418
|
4 043
|
4 244
|
4 847
|
8 582
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
51
|
4
|
7
|
3
|
3
|
3
|
2
|
2
|
4
|
2
|
101
|
217
|
153
|
172
|
322
|
560
|
321
|
|
| Total Current Assets |
261
|
986
|
1 312
|
3 402
|
3 572
|
2 936
|
2 607
|
2 559
|
2 094
|
2 156
|
2 439
|
3 429
|
5 088
|
4 402
|
4 839
|
4 505
|
5 314
|
5 936
|
9 023
|
12 012
|
16 753
|
22 041
|
|
| PP&E Net |
447
|
810
|
1 017
|
1 249
|
1 385
|
1 915
|
1 901
|
1 821
|
737
|
739
|
741
|
725
|
1 024
|
1 641
|
1 649
|
1 864
|
1 981
|
2 300
|
2 540
|
3 423
|
3 869
|
8 954
|
|
| PP&E Gross |
447
|
810
|
1 017
|
1 249
|
1 385
|
1 915
|
1 901
|
1 821
|
0
|
739
|
741
|
725
|
1 024
|
1 641
|
1 649
|
1 864
|
1 981
|
2 300
|
2 540
|
3 423
|
3 869
|
8 954
|
|
| Accumulated Depreciation |
103
|
166
|
236
|
314
|
386
|
634
|
741
|
852
|
0
|
453
|
513
|
563
|
617
|
748
|
890
|
1 032
|
1 149
|
1 331
|
1 564
|
2 044
|
2 363
|
3 511
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
402
|
1 479
|
1 691
|
2 049
|
552
|
481
|
420
|
352
|
276
|
328
|
313
|
402
|
483
|
474
|
586
|
708
|
727
|
|
| Goodwill |
0
|
0
|
0
|
0
|
13
|
387
|
424
|
406
|
0
|
363
|
339
|
311
|
283
|
779
|
697
|
617
|
314
|
244
|
196
|
300
|
385
|
409
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
41
|
12
|
15
|
8
|
101
|
6
|
8
|
13
|
33
|
26
|
26
|
9
|
229
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
100
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
35
|
0
|
|
| Other Long-Term Assets |
1
|
27
|
22
|
19
|
19
|
98
|
115
|
120
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
12
|
31
|
24
|
54
|
146
|
36
|
|
| Other Assets |
0
|
0
|
0
|
0
|
13
|
387
|
424
|
406
|
0
|
363
|
339
|
311
|
283
|
779
|
697
|
617
|
314
|
244
|
196
|
300
|
385
|
409
|
|
| Total Assets |
709
N/A
|
1 824
+157%
|
2 350
+29%
|
4 669
+99%
|
4 989
+7%
|
5 542
+11%
|
6 296
+14%
|
6 456
+3%
|
4 919
-24%
|
3 851
-22%
|
4 012
+4%
|
4 901
+22%
|
6 756
+38%
|
7 200
+7%
|
7 518
+4%
|
7 322
-3%
|
8 037
+10%
|
9 027
+12%
|
12 283
+36%
|
16 401
+34%
|
21 904
+34%
|
32 396
+48%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
36
|
397
|
365
|
332
|
446
|
686
|
811
|
595
|
551
|
586
|
561
|
832
|
1 070
|
1 190
|
1 618
|
778
|
1 061
|
1 103
|
1 687
|
2 001
|
2 306
|
3 057
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
72
|
72
|
72
|
89
|
110
|
104
|
195
|
|
| Short-Term Debt |
123
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 160
|
1 139
|
1 138
|
1 055
|
822
|
879
|
1 097
|
1 174
|
999
|
188
|
187
|
413
|
416
|
231
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
517
|
497
|
412
|
344
|
64
|
0
|
0
|
5
|
3
|
33
|
60
|
281
|
157
|
355
|
|
| Other Current Liabilities |
3
|
11
|
22
|
45
|
7
|
27
|
10
|
1
|
2 970
|
2 970
|
863
|
960
|
906
|
442
|
246
|
317
|
191
|
891
|
961
|
758
|
427
|
936
|
|
| Total Current Liabilities |
162
|
408
|
387
|
377
|
453
|
713
|
821
|
595
|
5 198
|
5 193
|
2 973
|
3 191
|
2 862
|
2 511
|
2 961
|
2 347
|
2 326
|
2 288
|
2 984
|
3 562
|
3 410
|
4 773
|
|
| Long-Term Debt |
432
|
953
|
898
|
3 039
|
3 187
|
3 407
|
3 965
|
4 240
|
190
|
152
|
79
|
198
|
0
|
125
|
110
|
100
|
100
|
125
|
143
|
414
|
657
|
2 633
|
|
| Deferred Income Tax |
5
|
21
|
42
|
57
|
85
|
0
|
0
|
0
|
157
|
131
|
26
|
23
|
15
|
24
|
41
|
60
|
70
|
108
|
81
|
176
|
154
|
37
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
3
|
7
|
9
|
25
|
56
|
70
|
66
|
81
|
84
|
62
|
95
|
102
|
131
|
189
|
207
|
199
|
225
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
10
|
11
|
14
|
15
|
21
|
19
|
33
|
59
|
|
| Total Liabilities |
599
N/A
|
1 381
+131%
|
1 327
-4%
|
3 473
+162%
|
3 725
+7%
|
4 123
+11%
|
4 794
+16%
|
4 845
+1%
|
5 570
+15%
|
5 531
-1%
|
3 148
-43%
|
3 479
+11%
|
2 958
-15%
|
2 751
-7%
|
3 184
+16%
|
2 613
-18%
|
2 612
0%
|
2 667
+2%
|
3 418
+28%
|
4 378
+28%
|
4 452
+2%
|
7 727
+74%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
100
|
235
|
494
|
494
|
494
|
494
|
503
|
503
|
503
|
503
|
520
|
520
|
534
|
409
|
409
|
409
|
409
|
409
|
409
|
409
|
453
|
453
|
|
| Retained Earnings |
1
|
197
|
198
|
427
|
495
|
649
|
560
|
624
|
1 608
|
2 579
|
96
|
519
|
1 622
|
2 258
|
2 176
|
2 482
|
3 202
|
4 074
|
6 572
|
9 247
|
11 055
|
17 499
|
|
| Additional Paid In Capital |
11
|
11
|
331
|
275
|
275
|
275
|
438
|
436
|
436
|
436
|
463
|
463
|
1 751
|
1 751
|
1 751
|
1 751
|
1 751
|
1 751
|
1 751
|
1 732
|
5 045
|
5 045
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
48
|
19
|
40
|
22
|
80
|
110
|
30
|
2
|
66
|
62
|
126
|
133
|
635
|
898
|
1 672
|
|
| Total Equity |
110
N/A
|
442
+302%
|
1 023
+131%
|
1 196
+17%
|
1 264
+6%
|
1 418
+12%
|
1 503
+6%
|
1 611
+7%
|
651
N/A
|
1 681
-158%
|
865
N/A
|
1 422
+64%
|
3 798
+167%
|
4 449
+17%
|
4 334
-3%
|
4 709
+9%
|
5 425
+15%
|
6 360
+17%
|
8 865
+39%
|
12 023
+36%
|
17 452
+45%
|
24 669
+41%
|
|
| Total Liabilities & Equity |
709
N/A
|
1 824
+157%
|
2 350
+29%
|
4 669
+99%
|
4 989
+7%
|
5 542
+11%
|
6 296
+14%
|
6 456
+3%
|
4 919
-24%
|
3 851
-22%
|
4 012
+4%
|
4 901
+22%
|
6 756
+38%
|
7 200
+7%
|
7 518
+4%
|
7 322
-3%
|
8 037
+10%
|
9 027
+12%
|
12 283
+36%
|
16 401
+34%
|
21 904
+34%
|
32 396
+48%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
100
|
100
|
359
|
359
|
359
|
359
|
368
|
368
|
368
|
368
|
385
|
385
|
409
|
409
|
409
|
409
|
409
|
409
|
409
|
409
|
453
|
453
|
|
| Preferred Shares Outstanding |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
